Zhengye Biotechnology Holding Limited
ZYBT
$6.70
-$2.79-29.40%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -64.90% | -59.09% | -55.44% | -45.15% | -35.69% |
| Total Depreciation and Amortization | -0.59% | 0.87% | 1.25% | 10.40% | 21.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.63% | -67.62% | -83.56% | -54.85% | -33.70% |
| Change in Net Operating Assets | 95.50% | 109.11% | 113.47% | 90.98% | 69.94% |
| Cash from Operations | -14.92% | 46.26% | 212.22% | 186.11% | 160.31% |
| Capital Expenditure | -83.78% | -33.00% | 11.40% | 59.87% | 75.11% |
| Sale of Property, Plant, and Equipment | -89.75% | 10.53% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -162.12% | -624.16% | -2,639.57% | -3,547.41% | -9,053.66% |
| Cash from Investing | -135.32% | -172.31% | -219.48% | -1.46% | 60.58% |
| Total Debt Issued | 13.03% | 6.54% | 0.05% | -11.10% | -20.02% |
| Total Debt Repaid | -69.17% | -46.31% | -26.96% | -5.70% | 15.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 60.08% | 20.60% | -36.98% | -53.43% | -72.91% |
| Other Financing Activities | 21.86% | -90.08% | -- | -- | -- |
| Cash from Financing | -18.97% | -125.09% | -288.60% | -1,574.42% | -213.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -147.36% | -254.58% | -633.03% | -47.43% | 250.67% |